focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Private Debt Investor Awards

17 Mar 2014 07:00

RNS Number : 3884C
Adamas Finance Asia Limited
17 March 2014
 



ADAMAS FINANCE ASIA LIMITED

 

Adamas Asset Management "just pipped" by global giant KKR as Asia Lender of the Year

 

 

17 March 2014: Hong Kong-based Adamas Asset Management, the investment manager of AIM-quoted Adamas Finance Asia Limited ("AFA"), has beaten major international competition to secure a top ranking in the prestigious Private Debt Investor Annual Awards 2013.

 

According to Private Debt Investor, Adamas was "just pipped" into second place by the global giant KKR Asset Management "in one of the most closely fought categories" to become a "highly commended" runner up for Asia Lender of the Year. More than 1,400 votes were cast for the Private Debt Investor Annual Awards 2013.

 

Adamas Asset Management ("Adamas"), which was established only four years ago, currently has around US$600 million under management. With effect from 19 February 2014 Adamas became investment manager to AFA following a reverse takeover in which AFA purchased a portfolio of four assets from a fund managed by Adamas.

 

Under a Services Agreement, the Adamas team is now supplying AFA with investment management services and access to deal flow, managed with a rigorous pre and post financing methodology. The investment programme will target Asian SME's needing capital, with a focus on Greater China.

 

Transactions introduced to AFA by Adamas will involve senior debt, bridge loans, mezzanine finance and other types of structured private financing. They will have a targeted internal rate of return of 15% - 20% per annum, with an average maturity of transactions ranging from 24 to 36 months.

 

Barry Lau, Managing Partner & CIO of Adamas, said: "The funding gap for SMEs in China is immense, currently estimated to be between US$1 trillion and US$5 trillion. Many of these SMEs lack necessary expansion capital from traditional banking channels. Adamas has successfully been providing growth capital to such growing SMEs by structuring collateralised direct loans, where possible with collateral held offshore. We believe the risk-adjusted returns offered by our strategy is a sound proposition for investors wishing to participate in the Chinese growth market without taking equity volatility risks."

 

Mr Lau added: "We are delighted to have won such strong recognition for our investment capabilities with the supporting votes of our partners and investors for the Asia Lender of the Year Category. It demonstrates that many sophisticated investors support our strategy."

 

"Adamas, in Chinese, is 'An De Si' and its meaning reflects our deep rooted philosophy that has been ingrained into the firm's DNA; 'An - De - Si' means 'Safety - Integrity - Thoughtfulness'."

 

 

Enquiries:

 

John Croft

Adamas Finance Asia Limited

 

+44 (0) 7785 315 588

Tim Feather

W H Ireland Limited

 

+44 (0) 113 394 6600

Allan Piper

First City Public Relations (Hong Kong)

 

+852 2854 2666

Simon Hudson

Tavistock Communications (London)

+44 (0) 20 7920 3170

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADMGMFKDRGDZM
Date   Source Headline
5th Dec 20169:00 amRNSDirector/PDMR Shareholding
28th Nov 201610:00 amRNSDirector/PDMR Shareholding
23rd Nov 20169:11 amRNSDirector/PDMR Shareholding
31st Oct 20168:05 amRNSDirector/PDMR Shareholding
24th Oct 20162:48 pmRNSDirector/PDMR Shareholding
17th Oct 201612:30 pmRNSDirector/PDMR Shareholding
12th Oct 20168:35 amRNSDirector/PDMR Shareholding
7th Oct 20168:45 amRNSre: redemption of Global Pharm Convertible Bond
6th Oct 20169:26 amRNSRestructuring of Investment in Fortel
29th Sep 20169:31 amRNSDirector/PDMR Shareholding
26th Sep 20167:00 amRNSReceipt of US$820,000 from GCCF
23rd Sep 20162:40 pmRNSDirector/PDMR Shareholding
16th Sep 201610:13 amRNSDirector/PDMR Shareholding
12th Sep 20168:54 amRNSHalf Yearly Report
1st Sep 20167:00 amRNSChange of Adviser
28th Jul 20164:40 pmRNSSecond Price Monitoring Extn
28th Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 201610:26 amRNSResult of AGM
6th Jul 20167:00 amRNSGCCF successfully exits Project Media
28th Jun 20168:37 amRNSRepayment of Loan by Portfolio Company
23rd Jun 20168:22 amRNSFinal Results
6th Apr 201610:36 amRNSRealisation of Investment in BRJ
1st Apr 201611:23 amRNSGlobal Pharm Update
31st Mar 20167:00 amRNSChange of Adviser
1st Mar 20169:37 amRNSDealing by Mark Hibbs
27th Jan 20168:01 amRNSGlobal Pharm Update
15th Jan 20169:34 amRNSDirector/PDMR Shareholding
7th Jan 20163:07 pmRNSUpdate on proposed IPO of HKMH
22nd Dec 201510:56 amRNSBroker Update
4th Dec 20157:00 amRNSAdamas AM & Ping An Trust Joint Venture Fund
30th Nov 20152:30 pmRNSGlobal Pharm Update
17th Nov 201512:04 pmRNSHolding(s) in Company
26th Oct 201510:56 amRNSRevised Redemption Agreement with Global Pharm
21st Oct 20158:49 amRNSRevised Redemption Agreement with Global Pharm
5th Oct 20157:00 amRNSADAM to invest a further $3m in Adamas' GCCF
18th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSAdamas Strengthens its Executive Team
20th Aug 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Jul 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
3rd Jul 20157:00 amRNSA1 Filing by HKMH
19th Jun 20157:00 amRNSFinal Results
15th Jun 201512:35 pmRNSUpdate on Disposal of Interest in Global Pharm
15th May 201512:09 pmRNSUpdate on Disposal of Interest in Global Pharm
29th Apr 20157:00 amRNSBroker Update
9th Apr 20158:37 amRNSAppointment of Broker
8th Apr 201510:53 amRNSResult of General Meeting
7th Apr 20154:40 pmRNSSecond Price Monitoring Extn
7th Apr 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Mar 20153:11 pmRNSChange of Investing Policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.